What You Should Know:
- Arkin Capital, a leading multi-asset investment manager, today announced the closing of Arkin Bio Ventures III, a $100 million fund focused on investing in advanced pre-clinical and early clinical-stage biotech companies developing transformative therapies in areas of high unmet medical need.
- The fund is backed by top-tier institutional investors, including Phoenix Insurance, Clal Insurance, and Amitim Pension Funds, alongside a significant investment from Arkin
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
How AI Automation in Wearables is Transforming Healthcare Systems
Wearable devices are transforming healthcare through continuous monitoring, early detection, and personalized management of chronic diseases. These innovations are reinventing how health concerns are tracked and treated, with the goal of improving diagnostics, outcomes, and accessibility. However, they also introduce new technical challenges to overcome.
Factors like increasing health consciousness, aging populations, and advances in sensor technology and connectivity are
Read More
Teladoc Health Unveils ‘Prism-Powered’ 24/7 Virtual Urgent Care for 100M Americans
What You Should Know
- Teladoc Health has launched significant enhancements to its 24/7 Care service, moving virtual urgent care from a simple transactional visit to a comprehensive, integrated clinical experience.
- Powered by the company’s Prism care delivery platform, the enhanced service now treats a broader range of conditions—from sleep issues to uncontrolled diabetes—while offering real-time specialist consults and integrated Health Information Exchange (HIE) data to identify gaps
Read More
Allos AI Raises $5M to Reformulate Complex Drugs with Glass-Box Causal AI
What You Should Know
- Allos AI has emerged from stealth with $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry’s first “glass-box” Causal AI platform.
- Unlike traditional AI that focuses on discovering new molecules, Allos targets the "formulation gap"—applying causal modeling to existing complex generics and next-generation medicines to improve their tolerability, bioavailability, and long-term patient outcomes.
The Problem: The
Read More
Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences
What You Should Know
- Anthropic has officially launched Claude for Healthcare, a suite of HIPAA-ready tools that allow providers and payers to use its latest model, Opus 4.5, for high-stakes medical tasks like prior authorization and claims appeals.
- Simultaneously, the company has significantly expanded Claude for Life Sciences, adding deep integrations with platforms like Medidata and ClinicalTrials.gov to automate clinical trial operations and regulatory submissions.
The Engine:
Read More
RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide
What You Should Know:
- RISA Labs, a company pioneering AI operating system for oncology, today announced the closing of an $11.1 million Series A funding round.
- The financing was co-led by Cencora Ventures and Optum Ventures, with participation from Oncology Ventures, Z21 Ventures, and John Simon (co-founder of General Catalyst).
RISA Labs Raises the Bar for AI-Driven Oncology Operations
Founded by RISA Labs co-founders Kshitij Jaggi and Kumar Shivang, RISA Labs is building
Read More
EnableComp Acquires H/ROI, Creating the Industry’s Most Comprehensive Complex Revenue Platform
What You Should Know:
- EnableComp®, recognized for resolving the toughest challenges in Complex Revenue Cycle Management, announced its acquisition of Health Resources Optimization, Inc. (H/ROI), a premier clinical denials and revenue recovery firm serving top health systems in the Northeast.
- As hospitals face sustained margin pressure from denials and payer scrutiny, the acquisition expands the revenue EnableComp captures for its clients by resolving and
Read More
Elation Health Cuts Chart Review Time 61% With Anthropic’s Claude AI
What You Should Know:
- Elation Health, the clinical-first technology company powering innovation in primary care, today announced that its Clinical Insights solution has moved to Claude Haiku 4.5 by Anthropic, the leading artificial intelligence research and development company with an emphasis on responsible AI.
- Clinical Insights delivers summaries of a patient's health story to clinicians at the point of care, using Claude’s speed and long-context reasoning for safe, accurate
Read More
Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics
What You Should Know
- Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics.
- The partnership includes the development of an exclusive, purpose-built AI model trained on Lilly’s proprietary data, leveraging Chai's Chai-2 platform to compress discovery timelines from months to weeks.
The "Zero-Shot" Revolution: Slashing Discovery Timelines
In the world of biologics, antibody design has
Read More
The Flight to Quality: Why 2026 Healthcare VC is Betting on AI Integration Over Innovation
Venture capital is making a comeback in healthcare, and this time, artificial intelligence (AI) is at the center of the movement.
According to Crunchbase, funding for AI-powered health-tech startups surged to an estimated $10.7 billion in 2025, a 24% increase over the previous year. That represents roughly one-third of all digital-health investments this year, signaling not just a rebound from prior market corrections but a renewed focus on technologies that deliver measurable clinical
Read More
